XML 36 R20.htm IDEA: XBRL DOCUMENT
v3.21.2

Income Per Share and Stockholders' Equity | 6 Months Ended
--- | ---
Jun. 30, 2021
Earnings Per Share And Stockholders Equity [Abstract] |
Income Per Share and Stockholders' Equity | Income Per Share and Stockholders' Equity The calculations of basic and diluted income per share attributable to CBRE Group, Inc. stockholders are as follows (dollars in thousands, except share and per share data):
| Three Months Ended June 30, |  | Six Months Ended June 30,
| 2021 |  | 2020 |  | 2021 |  | 2020
Basic Income Per Share |  |  |  |  |  |  |
Net income attributable to CBRE Group, Inc. stockholders | $ | 442,637 |  |  | $ | 81,897 |  |  | $ | 708,839 |  |  | $ | 254,092 |
Weighted average shares outstanding for basic income per share | 335,643,233 |  |  | 335,126,126 |  |  | 335,751,530 |  |  | 335,048,115 |
Basic income per share attributable to CBRE Group, Inc. stockholders | $ | 1.32 |  |  | $ | 0.24 |  |  | $ | 2.11 |  |  | $ | 0.76 |
Diluted Income Per Share |  |  |  |  |  |  |
Net income attributable to CBRE Group, Inc. stockholders | $ | 442,637 |  |  | $ | 81,897 |  |  | $ | 708,839 |  |  | $ | 254,092 |
Weighted average shares outstanding for basic income per share | 335,643,233 |  |  | 335,126,126 |  |  | 335,751,530 |  |  | 335,048,115 |
Dilutive effect of contingently issuable shares | 3,859,638 |  |  | 2,235,293 |  |  | 3,789,824 |  |  | 3,501,690 |
Weighted average shares outstanding for diluted income per share | 339,502,871 |  |  | 337,361,419 |  |  | 339,541,354 |  |  | 338,549,805 |
Diluted income per share attributable to CBRE Group, Inc. stockholders | $ | 1.30 |  |  | $ | 0.24 |  |  | $ | 2.09 |  |  | $ | 0.75 |
For the three and six months ended June 30, 2021, 3,974 and 15,852, respectively, of contingently issuable shares were excluded from the computation of diluted income per share because their inclusion would have had an anti-dilutive effect. For the three and six months ended June 30, 2020, 2,381,476 and 1,585,601, respectively, of contingently issuable shares were excluded from the computation of diluted income per share because their inclusion would have had an anti-dilutive effect. In February 2019, our board of directors authorized a new program for the repurchase of up to $300.0 million of our common stock over three years, effective March 11, 2019. In both August and November 2019, our board of directors authorized an additional $100.0 million under our program, bringing the total authorized repurchase amount under the program to a total of $500.0 million. During the year ended December 31, 2020, we spent $50.0 million to repurchase 1,050,084 shares of our common stock at an average price of $47.62 per share using cash on hand. During the three months ended March 31, 2021, we spent $64.1 million to repurchase an additional 831,274 shares of our common stock with an average price of $77.15 per share using cash on hand. During the three months ended June 30, 2021, we spent $24.1 million to repurchase an additional 300,454 shares of our common stock with an average price of $80.31 per share using cash on hand. As of June 30, 2021, we had $261.7 million of capacity remaining under our stock repurchase program.

X
- Definition Earnings per share and stockholders' equity. + References No definition available. + Details
Name: | cbre_EarningsPerShareAndStockholdersEquityAbstract
Namespace Prefix: | cbre_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Earnings per share and stockholder's equity. + References No definition available. + Details
Name: | cbre_EarningsPerShareAndStockholdersEquityTextBlock
Namespace Prefix: | cbre_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration